Soligenix (SNGX)
(Delayed Data from NSDQ)
$0.42 USD
-0.01 (-2.81%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.42 +0.01 (1.20%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SNGX 0.42 -0.01(-2.81%)
Will SNGX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SNGX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for SNGX
Soligenix extends patent protection for Filovirus Vaccine platform
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Friday's After-Market Session
Biotech Alert: Searches spiking for these stocks today
Soligenix prices $4.75M public offering at 40c per share